Chemistry:Nortilidine

From HandWiki
Short description: Chemical compound
Nortilidine
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
ChEMBL
Chemical and physical data
FormulaC16H21NO2
Molar mass259.349 g·mol−1
3D model (JSmol)

Nortilidine[1] is the major active metabolite of tilidine. It is formed from tilidine by demethylation in the liver. The racemate has opioid analgesic effects roughly equivalent in potency to that of morphine.[2] The (1R,2S) isomer has NMDA antagonist activity. The drug also acts as a dopamine reuptake inhibitor.[3] The reversed-ester of nortilidine is also known, as is the corresponding analogue with the cyclohexene ring replaced by cyclopentane,[4] which have almost identical properties to nortilidine.[5]

Use

Nortilidine has been sold as a designer drug, first being identified in Poland in May 2020.[6][7]

See also

  • Desmetramadol, another opioid metabolite with additional (non-opioid) mechanisms of analgesia, which has also been sold as a designer drug
  • Tapentadol

References

  1. ↑ "Process for Substituted Cyclohexenes its Products" US patent 3792080
  2. ↑ "Sequential first-pass metabolism of nortilidine: the active metabolite of the synthetic opioid drug tilidine". Journal of Clinical Pharmacology 42 (11): 1257–61. November 2002. doi:10.1177/009127002762491352. PMID 12412825. 
  3. ↑ "Novel psychoactive substances of interest for psychiatry". World Psychiatry 14 (1): 15–26. February 2015. doi:10.1002/wps.20174. PMID 25655145. 
  4. ↑ "Cycloaromatic compounds, analgesic Properties thereof and Method of use thereof as analgesic" US patent 4291059
  5. ↑ Personal Communication with Derek P. Reynolds
  6. ↑ "EU Early Warning System Situation Report. Situation report 2". European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 10 August 2020. 
  7. ↑ "Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach". Frontiers in Psychiatry 11: 632405. 2020. doi:10.3389/fpsyt.2020.632405. PMID 33633599.